Latest Period
Q4 2025
Security Snapshot
agilon health, inc. - Common Stock (AGL) Institutional Ownership
CUSIP: 00857U107
13F Institutional Holders and Ownership History from Q2 2021 to Q1 2026
Institutions Reporting
195
Shares (Excl. Options)
371,297,575
Price
$0.69
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place.
- Type / Class
- Equity / Common Stock
- Symbol
- AGL on NYSE
- Shares outstanding
- 415,460,499
- Price per share
- $5.53
- All holders as of 31 Dec 2025
- Q4 2025
- Total 13F shares
- 371,297,575
- Total reported value
- $255,908,991
- % of total 13F portfolios
- 0%
- Share change
- -9,129,125
- Value change
- -$10,790,545
- Number of holders
- 195
- Price from insider filings
- $5.53
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- AGL - agilon health, inc. - Common Stock is tracked under CUSIP 00857U107.
- 195 institutions reported positions in Q4 2025.
- 7 significant owners is listed from Schedule 13D/13G reporting.
What Changed
- Holder count moved from 195 to 2 between Q4 2025 and Q1 2026.
- Reported value moved from $255,908,991 to $1,160,181.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Source Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 195 institutions filings for Q4 2025.
Investment Quick Answers
What is CUSIP 00857U107?
CUSIP 00857U107 identifies AGL - agilon health, inc. - Common Stock in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Next ownership checks
Use the next link that matches the question you still need to answer about this security.
- Latest 13F filings when you want to inspect fresh institutional portfolio moves.
- Latest Schedule 13D/13G reports when you need large-owner changes outside the 13F cycle.
- All institutional ownership pages to compare this security with other holder-history pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 00857U107:
Significant Owners of agilon health, inc. - Common Stock (AGL) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| MORGAN STANLEY | 12% | $192,768,956 | 50,200,249 | Morgan Stanley | 31 Mar 2025 | |||
| North Peak Capital Management, LLC | 9.5% | +86% | $40,594,316 | +$18,411,536 | 39,411,957 | +83% | North Peak Capital Management, LLC | 30 Sep 2025 |
| VANGUARD GROUP INC | 4.4% | -24% | $12,618,229 | -$4,112,087 | 18,321,808 | -25% | The Vanguard Group | 31 Dec 2025 |
| FMR LLC | 3.7% | -63% | $15,838,857 | -$24,084,688 | 15,377,531 | -60% | FMR LLC | 30 Sep 2025 |
| WELLINGTON MANAGEMENT GROUP LLP | 3.6% | -47% | $57,549,684 | -$51,420,591 | 14,986,897 | -47% | Wellington Management Group LLP | 31 Mar 2025 |
| Capital World Investors | 2.6% | -76% | $9,333,531 | -$29,857,186 | 10,852,943 | -76% | Capital World Investors | 29 Aug 2025 |
| Capital International Investors | 2.4% | -60% | $22,060,815 | -$27,739,262 | 9,892,742 | -56% | Capital International Investors | 30 Jun 2025 |
As of 31 Dec 2025, 195 institutional investors reported holding 371,297,575 shares of agilon health, inc. - Common Stock (AGL). This represents 89% of the company’s total 415,460,499 outstanding shares.
Top 25 Institutional Shareholders
The largest institutional shareholders of agilon health, inc. - Common Stock (AGL) together control 84% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| Clayton, Dubilier & Rice, LLC | 24% | 100,000,000 | 0% | 12% | $69,000,000 |
| MORGAN STANLEY | 13% | 53,877,223 | -9.3% | 0% | $37,105,242 |
| North Peak Capital Management, LLC | 9.2% | 38,139,937 | +11% | 2.9% | $26,266,975 |
| BlackRock, Inc. | 5.4% | 22,615,061 | -6.5% | 0% | $15,574,993 |
| D. E. Shaw & Co., Inc. | 4.9% | 20,311,334 | +103% | 0.01% | $13,988,415 |
| GOLDMAN SACHS GROUP INC | 4.8% | 20,055,214 | +196% | 0% | $13,812,025 |
| VANGUARD GROUP INC | 4.4% | 18,321,808 | -25% | 0% | $12,623,725 |
| AQR CAPITAL MANAGEMENT LLC | 2.5% | 10,211,767 | +1347% | 0% | $7,032,843 |
| Capital World Investors | 2% | 8,364,227 | 0% | 0% | $5,760,443 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.9% | 8,019,002 | +31% | 0% | $5,522,687 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.7% | 7,177,477 | +0.49% | 0% | $4,944,078 |
| CenterBook Partners LP | 1.7% | 7,021,522 | -39% | 0.24% | $4,835,722 |
| Rock Springs Capital Management LP | 1.6% | 6,500,000 | -6.7% | 0.23% | $4,476,550 |
| STATE STREET CORP | 1.5% | 6,318,625 | -18% | 0% | $4,351,637 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 0.97% | 4,037,979 | +30% | 0.01% | $2,780,956 |
| UBS Group AG | 0.82% | 3,395,366 | +251% | 0% | $2,339,407 |
| FMR LLC | 0.69% | 2,882,933 | -82% | 0% | $1,985,476 |
| RENAISSANCE TECHNOLOGIES LLC | 0.57% | 2,371,037 | +62% | 0% | $1,632,933 |
| NORTHERN TRUST CORP | 0.55% | 2,286,186 | -14% | 0% | $1,574,496 |
| GSA CAPITAL PARTNERS LLP | 0.49% | 2,044,795 | 0.12% | $1,408,000 | |
| Amundi | 0.47% | 1,969,309 | 0% | $1,356,263 | |
| CITADEL ADVISORS LLC | 0.3% | 1,240,086 | -68% | 0% | $854,047 |
| Numerai GP LLC | 0.3% | 1,228,071 | +207% | 0.1% | $845,772 |
| TWO SIGMA ADVISERS, LP | 0.27% | 1,114,200 | 0% | $767,350 | |
| TWO SIGMA INVESTMENTS, LP | 0.27% | 1,108,391 | 0% | $763,349 |
Institutional Holders of agilon health, inc. - Common Stock (AGL) across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 114,000 | $1,160,181 | -$5,068,318 | $5.53 | 2 |
| 2025 Q4 | 371,297,575 | $255,908,991 | -$10,790,545 | $0.69 | 195 |
| 2025 Q3 | 381,667,622 | $393,148,245 | -$40,840,326 | $1.03 | 188 |
| 2025 Q2 | 399,328,682 | $918,636,706 | -$2,996,581 | $2.30 | 204 |
| 2025 Q1 | 399,826,350 | $1,730,807,498 | -$76,575,360 | $4.33 | 198 |
| 2024 Q4 | 416,234,592 | $791,149,797 | -$48,593,665 | $1.90 | 183 |
| 2024 Q3 | 430,599,052 | $1,691,470,202 | -$113,061,378 | $3.93 | 208 |
| 2024 Q2 | 455,653,328 | $2,979,967,947 | +$79,546,138 | $6.54 | 201 |
| 2024 Q1 | 443,787,505 | $2,706,552,672 | -$123,526,322 | $6.10 | 196 |
| 2023 Q4 | 448,445,736 | $5,627,999,290 | -$86,646,980 | $12.55 | 191 |
| 2023 Q3 | 453,084,974 | $8,047,230,241 | +$191,740,226 | $17.76 | 182 |
| 2023 Q2 | 441,924,134 | $7,662,666,468 | -$98,821,035 | $17.34 | 185 |
| 2023 Q1 | 447,304,552 | $10,625,730,982 | +$380,606,408 | $23.75 | 201 |
| 2022 Q4 | 431,582,727 | $6,968,757,708 | +$108,690,436 | $16.14 | 168 |
| 2022 Q3 | 423,431,419 | $9,916,406,555 | +$176,516,049 | $23.42 | 171 |
| 2022 Q2 | 413,012,885 | $9,021,247,394 | +$291,140,328 | $21.83 | 142 |
| 2022 Q1 | 399,667,807 | $10,129,841,658 | +$205,624,833 | $25.35 | 117 |
| 2021 Q4 | 390,547,332 | $10,544,871,738 | +$1,563,624,581 | $27.00 | 125 |
| 2021 Q3 | 332,148,873 | $8,681,146,469 | +$10,635,889 | $26.21 | 99 |
| 2021 Q2 | 330,692,941 | $13,244,783,310 | +$13,244,729,185 | $40.57 | 92 |